Biomanufacturing 4.0 - A New Era in Cell and Gene Therapy Development

A webinar is conducted on Biomanufacturing 4.0 by BIS Research.
Cell and gene therapy are promising fields of biomedical research that focus on developing new treatments for a range of diseases by modifying cells and genes.
On one hand, a cell therapy involves the use of living cells as therapeutic agents to treat a variety of medical conditions, including cancer, immune disorders, and genetic diseases. The cells used in these therapies can be either from the patient's own body (autologous) or from a donor (allogeneic).
Biomanufacturing 4.0 is a new approach to biomanufacturing that integrates advanced technologies, such as automation, artificial intelligence, machine learning, and big data analytics, to improve the efficiency, quality, and scalability of bioproduction processes. It is also known as "digital biomanufacturing" or "smart biomanufacturing."
So, how exactly is this new revolution in cell and gene therapy going to impact the overall healthcare sector? To understand this, and more, BIS Research conducted a webinar by involving some of the brightest minds from the field of biopharma and healthcare manufacturing.
Related Reports by BIS Research:
bisresearch.com/industry-repo...
bisresearch.com/industry-repo...
bisresearch.com/industry-repo...
Check out some reports on healthcare industry by BIS Research at: bisresearch.com/industry-vert...